Musk's brain-computer company Neuralink prepares to launch first human trial

According to news from this site on September 20, in May this year, Neuralink, a brain-computer interface startup company owned by Musk, obtained human clinical trial permission from the U.S. Food and Drug Administration (FDA), which can use its brain implants and Surgical robots are being tested.

On Tuesday local time, Neuralink announced that it had received review approval and hospital site approval, and its first-in-human clinical trial was open for enrollment. Neuralink said patients with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) may be eligible for testing.

This six-year preliminary trial is called the "PRIME study" by Neuralink, which stands for "Precision Robotic Implantable Brain-Computer Interface" ( Note on this site: That is Precise Robotically Implanted Brain-Computer Interface)".

According to reports, the project aims to evaluate the safety and functionality of its fully implantable wireless brain-computer interface, focusing on three parts: N1 implant, R1 robot, and N1 user application.

The study will use a surgical robot to implant the N1 implant into the area of ​​the brain that controls movement intentions (it will look the same as ordinary people after placement), and then use this App to connect to N1 and transmit neural signals Converted to computer action.

Our initial goal with BCI is to achieve control of a computer cursor or keyboard through thought

Researchers have been testing implants, according to two recent studies , to help paralyzed patients control computers and other devices. These studies suggest that brain-computer interface technology can help ALS patients communicate by typing on computers

According to Neuralink, participants in the PRIME study will initially be part of an 18-month study that will include nine researchers Access. After that, they will need to spend at least two hours a week attending brain-computer interface research sessions and conduct another 20 visits over the next five years. Although the specific number of subjects and the planned start time of the research were not disclosed. , Neuralink has confirmed that it will compensate for research-related expenses, such as transportation costs to and from the research site

Related reading:

"Musk: Neuralink will implant a brain-computer interface into the human body this year First trial》

Musk’s brain-computer interface company Neuralink recently successfully received $280 million in financing and has previously received approval for human clinical trials

Advertising statement: This article contains External jump links (including but not limited to hyperlinks, QR codes, passwords, etc.) are designed to provide more information and save screening time. The results are for reference only. Please note that all articles on this site carry this statement

The above is the detailed content of Musk's brain-computer company Neuralink prepares to launch first human trial. For more information, please follow other related articles on the PHP Chinese website!